the17th Annual Scientific Meeting of the EAO
2 مشترك
صفحة 1 من اصل 1
the17th Annual Scientific Meeting of the EAO
Straumann Presents 'Roxolid™' A New Material Designed To Enhance The Strength And Healing Properties Of Dental Implants
date : 23 Sep 2008
At the17th Annual Scientific Meeting of the European Association for Osseointegration (EAO) in Warsaw, Poland, Straumann presented a new material that could make dental implants smaller and stronger. The new material, which is called Roxolid™, is an alloy of titanium and zirconium and is the first material to be designed specifically for dental implants.
Roxolid™ is 50% stronger than pure titanium[1], the current material of choice for implants. Exciting preclinical study results presented in Warsaw showed that Roxolid integrated with bone better than pure titanium[2]. The combination of enhanced strength and osseointegration could open the door for a new generation of smaller, safer implants, which would be particularly advantageous in situations where there is limited space between teeth. A further potential advantage could be the use in thin bone (narrow bone ridge), where wider implants would necessitate bone augmentation/grafting procedures.
Engineered and developed by Straumann, Roxolid is currently undergoing clinical trials in 6 countries. Preliminary (6-12 month) observations from the first clinical trial were also presented at the EAO[3] showing very promising survival rates.
Pending regulatory approvals and further positive findings from the broad clinical program, Roxolid implants are expected to become available in initial markets in the course of 2009.
date : 23 Sep 2008
At the17th Annual Scientific Meeting of the European Association for Osseointegration (EAO) in Warsaw, Poland, Straumann presented a new material that could make dental implants smaller and stronger. The new material, which is called Roxolid™, is an alloy of titanium and zirconium and is the first material to be designed specifically for dental implants.
Roxolid™ is 50% stronger than pure titanium[1], the current material of choice for implants. Exciting preclinical study results presented in Warsaw showed that Roxolid integrated with bone better than pure titanium[2]. The combination of enhanced strength and osseointegration could open the door for a new generation of smaller, safer implants, which would be particularly advantageous in situations where there is limited space between teeth. A further potential advantage could be the use in thin bone (narrow bone ridge), where wider implants would necessitate bone augmentation/grafting procedures.
Engineered and developed by Straumann, Roxolid is currently undergoing clinical trials in 6 countries. Preliminary (6-12 month) observations from the first clinical trial were also presented at the EAO[3] showing very promising survival rates.
Pending regulatory approvals and further positive findings from the broad clinical program, Roxolid implants are expected to become available in initial markets in the course of 2009.
this is only a part from the article
get all of it from here : http://www.medicalnewstoday.com/articles/122469.php
really you ll enjoy reading it
get all of it from here : http://www.medicalnewstoday.com/articles/122469.php
really you ll enjoy reading it
رد: the17th Annual Scientific Meeting of the EAO
ياريت والله ... دي تبقى حاجة كويسه جدا ان الالتئام يحصل بسرعه
رد: the17th Annual Scientific Meeting of the EAO
مش بس ال healing او الالتئام المقال ليه باقي في اللينك اللي انا كاتبه
بيوضح باقي الخواص للماده دي
بجد مقال جميل جدا
بيوضح باقي الخواص للماده دي
بجد مقال جميل جدا
صفحة 1 من اصل 1
صلاحيات هذا المنتدى:
لاتستطيع الرد على المواضيع في هذا المنتدى